Literature DB >> 6801095

Monoclonal gammopathies in the adult population of Finistère, France.

J P Saleun, M Vicariot, P Deroff, J F Morin.   

Abstract

Three hundred and thirty-four monoclonal gammopathies were detected in the sera of 30 279 adults from Finistère. Monoclonal gammopathies (MG) are more common in Finistère than in Paris and their distribution is not homogeneous. IgG paraproteins are particularly common in the northeast of Finistère whereas IgM paraproteins are more common in the southwest. Family studies and the high degree of inbreeding would support the hypothesis that there is a genetic predisposition to develop MG but the occurrence of paraproteins among three non-consanguineous couples seems to favour the existence of an environmental factor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6801095      PMCID: PMC497449          DOI: 10.1136/jcp.35.1.63

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  24 in total

1.  The incidence of myelomatosis.

Authors:  N H MARTIN
Journal:  Lancet       Date:  1961-02-04       Impact factor: 79.321

2.  Lymphoreticular tumors in Norway and in other European countries.

Authors:  H Stalsberg
Journal:  J Natl Cancer Inst       Date:  1973-06       Impact factor: 13.506

3.  Frequency of pathological proteins (M-components) om 6,995 sera from an adult population.

Authors:  U Axelsson; R Bachmann; J Hällén
Journal:  Acta Med Scand       Date:  1966-02

4.  ["Essential" dysglobulinemia in aged subjects].

Authors:  C Derycke; J M Fine; G A Boffa
Journal:  Nouv Rev Fr Hematol       Date:  1965 Sep-Oct

5.  Frequency of monoclonal gammapathy ('M components') in 13,400 sera from blood donors.

Authors:  J M Fine; P Lambin; P Leroux
Journal:  Vox Sang       Date:  1972       Impact factor: 2.144

6.  The incidence of malignant lymphoma and multiple myeloma in Hiroshima and Nagasaki atomic bomb survivors, 1945-1965.

Authors:  H Nishiyama; R E Anderson; T Ishimaru; K Ishida; Y Ii; N Okabe
Journal:  Cancer       Date:  1973-12       Impact factor: 6.860

7.  [Electrophoretical, class and group distribution of "paraproteins" and normal immunoglobulins].

Authors:  A Fateh-Moghadam; R Lamerz; M Knedel; B Tsirimbas
Journal:  Klin Wochenschr       Date:  1971-04-15

8.  Immunoglobulin analysis in families of myeloma patients.

Authors:  H Odeberg; B G Johansson; S O Berlin
Journal:  Acta Med Scand       Date:  1974-11

9.  Immunoglobulin abnormalities in families of patients with Waldenström's macroglobulinemia.

Authors:  M Seligmann; F Danon; C Mihaesco; H H Fudenberg
Journal:  Am J Med       Date:  1967-07       Impact factor: 4.965

10.  [Monoclonal gammapathies. (Critical review of 219 cases collected over 3 years)].

Authors:  P Youinou; P Le Goff; J P Saleun; J Jouquan; G Tymen; G Le Menn
Journal:  Pathol Biol (Paris)       Date:  1977-10
View more
  32 in total

Review 1.  Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

Authors:  Robert A Kyle; S Vincent Rajkumar
Journal:  Curr Hematol Malig Rep       Date:  2010-04       Impact factor: 3.952

Review 2.  Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).

Authors:  Robert A Kyle; S Vincent Rajkumar
Journal:  Oncology (Williston Park)       Date:  2011-06       Impact factor: 2.990

3.  CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.

Authors:  M Zandecki; T Facon; F Bernardi; V Izydorczyk; L Dupond; M François; R Reade; T Iaru; F Bauters; A Cosson
Journal:  J Clin Pathol       Date:  1995-06       Impact factor: 3.411

4.  Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma.

Authors:  Rishi K Wadhera; Robert A Kyle; Dirk R Larson; Angela Dispenzieri; Shaji Kumar; Hillard M Lazarus; S Vincent Rajkumar
Journal:  Blood       Date:  2011-07-15       Impact factor: 22.113

5.  The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings.

Authors:  K B Yeung; P K Thomas; R H King; H Waddy; R G Will; R A Hughes; N A Gregson; S Leibowitz
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

Review 6.  Precursors to lymphoproliferative malignancies.

Authors:  Lynn R Goldin; Mary L McMaster; Neil E Caporaso
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04       Impact factor: 4.254

7.  Occurrence of serum M-protein species in Japanese patients older than 50 years based on relative mobility in cellulose acetate membrane electrophoresis.

Authors:  Y Kurihara; K Shiba; Y Fukumura; I Kobayashi; S Kamei
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

8.  ["Benign" monoclonal gammopathy and chronic lymphatic leukemia in a patient with Noonan syndrome].

Authors:  J Riederer
Journal:  Med Klin (Munich)       Date:  1998-07-15

Review 9.  Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: a review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease.

Authors:  Amit Agarwal; Irene M Ghobrial
Journal:  Clin Cancer Res       Date:  2012-12-05       Impact factor: 12.531

10.  Change in relative mobility of M protein following neuraminidase treatment in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.

Authors:  Yuriko Kurihara; Shiro Iijima; Kouhei Fukushima; Toshiaki Hosaka; Kiyoko Shiba
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.